Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment.
Sinzinger
H
H
Schmid
P
P
O'Grady
J
J
D000293:Adolescent; D000328:Adult; D003402:Creatine Kinase / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D015444:Exercise; D005229:Fatty Acids, Monounsaturated / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D000077340:Fluvastatin; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D006938:Hyperlipoproteinemia Type II / Q000150:complications / Q000188:drug therapy*; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use; D008148:Lovastatin / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009120:Muscle Cramp / Q000139:chemically induced*; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000378:metabolism; D010146:Pain / Q000139:chemically induced* / Q000378:metabolism; D017035:Pravastatin / Q000009:adverse effects / Q000627:therapeutic use; D011379:Prognosis; D018570:Risk Assessment; D019821:Simvastatin / Q000009:adverse effects / Q000627:therapeutic use; D013177:Sports
D005229:Fatty Acids, Monounsaturated; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007211:Indoles; D000077340:Fluvastatin; D008148:Lovastatin; D019821:Simvastatin; D003402:Creatine Kinase; D017035:Pravastatin